Overexpression of the anti-apoptotic protein BCL-2 is a key factor in the pathogenesis of chronic lymphocytic leukemia (CLL) and is associated with poor clinical outcomes. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.